Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 1
1995 4
1996 7
1997 2
1998 3
1999 5
2000 4
2001 4
2002 5
2003 3
2004 4
2005 4
2006 8
2007 13
2008 13
2009 14
2010 9
2011 19
2012 18
2013 30
2014 27
2015 16
2016 23
2017 19
2018 22
2019 27
2020 31
2021 44
2022 19
Text availability
Article attribute
Article type
Publication date

Search Results

350 results
Results by year
Filters applied: . Clear all
Page 1
Comparative efficacy and safety of systemic therapies used in moderate-to-severe atopic dermatitis: a systematic literature review and network meta-analysis.
Silverberg JI, Thyssen JP, Fahrbach K, Mickle K, Cappelleri JC, Romero W, Cameron MC, Myers DE, Clibborn C, DiBonaventura M. Silverberg JI, et al. Among authors: cappelleri jc. J Eur Acad Dermatol Venereol. 2021 Sep;35(9):1797-1810. doi: 10.1111/jdv.17351. Epub 2021 Jun 12. J Eur Acad Dermatol Venereol. 2021. PMID: 33991374 Free PMC article. Review.
Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-Analysis.
Fahrbach K, Tarpey J, Washington EB, Hughes R, Thom H, Neary MP, Cha A, Gerber R, Cappelleri JC. Fahrbach K, et al. Among authors: cappelleri jc. Dermatol Ther (Heidelb). 2020 Aug;10(4):681-694. doi: 10.1007/s13555-020-00389-5. Epub 2020 May 20. Dermatol Ther (Heidelb). 2020. PMID: 32435999 Free PMC article.
Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden-a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugs.
Strand V, de Vlam K, Covarrubias-Cobos JA, Mease PJ, Gladman DD, Graham D, Wang C, Cappelleri JC, Hendrikx T, Hsu MA. Strand V, et al. Among authors: cappelleri jc. RMD Open. 2019 Jan 11;5(1):e000806. doi: 10.1136/rmdopen-2018-000806. eCollection 2019. RMD Open. 2019. PMID: 30713721 Free PMC article. Clinical Trial.
Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.
Hoaglin DC, Hawkins N, Jansen JP, Scott DA, Itzler R, Cappelleri JC, Boersma C, Thompson D, Larholt KM, Diaz M, Barrett A. Hoaglin DC, et al. Among authors: cappelleri jc. Value Health. 2011 Jun;14(4):429-37. doi: 10.1016/j.jval.2011.01.011. Value Health. 2011. PMID: 21669367 Free article.
Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.
Jansen JP, Fleurence R, Devine B, Itzler R, Barrett A, Hawkins N, Lee K, Boersma C, Annemans L, Cappelleri JC. Jansen JP, et al. Among authors: cappelleri jc. Value Health. 2011 Jun;14(4):417-28. doi: 10.1016/j.jval.2011.04.002. Value Health. 2011. PMID: 21669366 Free article.
Symptom burden of patients with moderate-to-severe atopic dermatitis.
Egeberg A, Anderson P, Piercy J, Massey L, Cappelleri JC, Encinas GA, Feeney C, Dibonaventura M. Egeberg A, et al. Among authors: cappelleri jc. Eur J Dermatol. 2021 Dec 1;31(6):752-758. doi: 10.1684/ejd.2021.4166. Eur J Dermatol. 2021. PMID: 34935621
350 results